Kairav Vakil is a Cardiology physician affiliated with Minneapolis VA Health Care System. OpenAlex indexes 50 publications with 1,552 citations (h-index 18).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6405 France Ave S Ste W200
Minneapolis, MN 55435
Telephone
612-365-5000Registry record last updated 21 Jun 2018.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alnylam Pharmaceuticals Inc.Program year202511 payments$15,498openpaymentsdata.cms.gov ↗
- BridgeBio Pharma, Inc.Program year202511 payments$15,370openpaymentsdata.cms.gov ↗
- Abbott LaboratoriesProgram year202520 payments$11,020openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
81.9%Beta blocker22.3%Metoprolol Succinate48%Carvedilol38%Metoprolol Tartrate11%Sotalol3%Part D<11 patientsStatin17.1%Atorvastatin Calcium51%Rosuvastatin Calcium41%Pravastatin Sodium6%Simvastatin2%Part D<11 patients+ 15 more classes in this area
Blood & clotting
10%Factor Xa inhibitor7.9%Eliquis59%Xarelto41%Part D≥45 patientsP2Y12 inhibitor1.8%Clopidogrel100%Part D≥18 patients+ 1 more class in this area
Metabolism & gastrointestinal
6.1%SGLT2 inhibitor4%Jardiance76%Farxiga24%Part D<11 patientsPotassium supplement2.1%Potassium Chloride78%Klor-Con M2022%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Hospital Readmission Rates Following AMI: Potential Interventions to Improve Efficiency
Southern Medical Journal
2018 - Association of cardiac implantable electronic devices with survival in bifascicular block and prolonged PR interval on electrocardiogram
Journal of Interventional Cardiac Electrophysiology
2018 - Efficacy of Implantable Cardioverter-Defibrillator Therapy in Patients With Nonischemic Cardiomyopathy
JACC. Clinical electrophysiology
2017
Similar KOLs
Other experts from the same institution or the same specialty.
Maurice Dysken, MD
Minneapolis VA Health Care System
Suzanne Swan, MD
Minneapolis VA Health Care System
Anjum Kaka, MD
Minneapolis VA Health Care System
Pamela Shultz, MD
Minneapolis VA Health Care System
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”